Interclean Shanghai

Nucletron releases new version of Oncentra 3.3

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Nucletron released their new version of their Oncentra® treatment planning solution for clinical use. Oncentra® version 3.3 now includes state-of-the-art functionality including planning for volumetric modulated arc therapy (VMAT) and model based segmentation (MBS) tools.

Oncentra version 3.3 is the second release this year for Nucletron’s Oncentra treatment planning solution suite, also known as the Oncentra Dynamic Planning Environment. Version 3.3 includes numerous improvements as well as new modules for VMAT planning and for model based segmentation.

Oncentra® VMAT is an independent planning solution for volumetric-modulated arc therapy that can be used with the leading linear accelerators on the market. Available as a module within Oncentra version 3.3 Dynamic Planning Environment, the new planning option can be used with any VMAT-capable delivery system on the market, and offers the most flexible as well as the fastest VMAT planning tools available.

Oncentra® MBS is a tool that speeds up the process of organ and target contouring. From a library of pre-defined 3D organ models, the physician just needs to simply drag and drop anatomical templates onto the patient image data.  Oncentra MBS software then automatically adapts the shape to fit the patient’s organs.  This reduces the time it takes to manually draw contours. Oncentra MBS provides highly advanced organ delineation tools to support both brachytherapy and external beam planning. The result is consistent contours in dramatically reduced time.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »